Cited by 144Per- and polyfluoroalkyl substances researchToxic Organic Pollutants ImpactEffects and risks of endocrine disrupting chemicals

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages

Open access

Loccisano, Anne E., Longnecker, Matthew P., Campbell, Jerry L., Andersen, Melvin E., Clewell, Harvey J.·2013·Journal of Toxicology and Environmental Health, Part A

DOI 10.1080/15287394.2012.722523PMC PMC3502013

Open this paper in CoChat — free account

Abstract

Perfluoroalkyl acid carboxylates and sulfonates (PFAA) have many consumer and industrial applications. Developmental toxicity studies in animals have raised concern about potential reproductive/developmental effects of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS); however, in humans conflicting results have been reported for associations between maternal PFAA levels and these outcomes. Risk assessments and interpretation of available human data during gestation and lactation are hindered due to lack of a framework for understanding and estimating maternal, fetal, and neonatal pharmacokinetics (PK). Physiologically based pharmacokinetic (PBPK) models were developed for PFOA and PFOS for the gestation and lactation life stages in humans to understand how the physiological changes associated with development affect pharmacokinetics of these compounds in the mother, fetus, and infant. These models were derived from PBPK models for PFOA/PFOS that were previously developed for adult humans and rats during gestation and lactation and from existing human pregnancy and lactation models developed for other chemicals. The models simulated PFOA and PFOS concentrations in fetal, infant, and maternal plasma and milk, were compared to available data in humans, and also were used to estimate maternal exposure. The models reported here identified several research needs, which include (1) the identification of transporters involved in renal resorption to explain the multiyear half-lives of these compounds in humans, (2) factors affecting clearance of PFOA/PFOS during gestation and lactation, and (3) data to estimate clearance of PFOA/PFOS in infants. These models may help address concerns regarding possible adverse health effects due to PFOA/PFOS exposure in the fetus and infant and may be useful in comparing pharmacokinetics across life stages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1080/15287394.2012.722523

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426
2000 CDC Growth Charts for the United States: methods and development.
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer‐Strawn, L. M., Flegal, K. M., Mei, Z., Wei, R. X., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PubMed · Cited by 3,716
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,930
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
Sources, fate and transport of perfluorocarboxylates
Prevedouros, K., Cousins, I. T., Buck, R. C., & Korzeniowski, S. H. (2006) · Environmental Science & Technology · doi:10.1021/es0512475 · Cited by 2,594
Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Polyfluorinated Compounds: Past, Present, and Future
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011) · Environmental Science & Technology · doi:10.1021/es2011622 · Cited by 1,628
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models
Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997) · Toxicology and Industrial Health · doi:10.1177/074823379701300401 · Cited by 1,408
Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and Comparisons with NHANES 1999–2000
Calafat, A. M., Wong, L.-Y., Kuklenyik, Z., Reidy, J. A., & Needham, L. L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10598 · Cited by 1,247
Organohalogen compounds
(1995) · Environmental Science and Pollution Research · doi:10.1007/bf02986737 · Cited by 1,126
A first global production, emission, and environmental inventory for perfluorooctane sulfonate
Paul, A. G., Jones, K. C., & Sweetman, A. J. (2009) · Environmental Science & Technology · doi:10.1021/es802216n · Cited by 1,096
Perfluorinated compounds – Exposure assessment for the general population in western countries
Fromme, H., Tittlemier, S. A., Völkel, W., Wilhelm, M., & Twardella, D. (2008) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2008.04.007 · Cited by 979
The Developmental Toxicity of Perfluoroalkyl Acids and Their Derivatives
Lau, C., Butenhoff, J. L., & Rogers, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.11.031 · Cited by 867
Dietary Reference Intakes: the Essential Guide to Nutrient Requirements edited by JJ Otten, JP Hellwig, and LD Meyers, 2006, 560 pages, hardcover, $44.96. The National Academies Press, Washington, DC
Medeiros, D. M. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.924 · Cited by 765
Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: A critical review of recent literature
Post, G. B., Cohn, P. D., & Cooper, K. R. (2012) · Environmental Research · doi:10.1016/j.envres.2012.03.007 · Cited by 639
Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort
Fei, C., McLaughlin, J. K., Tarone, R. E., & Olsen, J. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10506 · Cited by 636
Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth
Apelberg, B. J., Witter, F. R., Herbstman, J. B., Calafat, A. M., Halden, R. U., Needham, L. L., & Goldman, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10334 · Cited by 630
Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys
Seacat, A. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.249 · Cited by 564
Effects of Perfluorooctanoic Acid Exposure during Pregnancy in the Mouse
Lau, C. S., Thibodeaux, J. R., Hanson, R. G., Narotsky, M. G., Rogers, J. M., Lindstrom, A. B., & Strynar, M. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj105 · Cited by 554
Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. II: Postnatal Evaluation
Lau, C., Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Stanton, M. E., Butenhoff, J. L., & Stevenson, L. A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg122 · Cited by 549
DRI, Dietary reference intakes : the essential guide to nutrient requirements
Otten, J. J., Hellwig, J. P., & Meyers, L. (2006) · Cited by 539
Estimating Consumer Exposure to PFOS and PFOA
Trudel, D., Horowitz, L., Wormuth, M., Scheringer, M., Cousins, I. T., & Hungerbühler, K. (2008) · Risk Analysis · doi:10.1111/j.1539-6924.2008.01017.x · Cited by 514 · cited 3×
“Because food intake has been suggested to be the main exposure route to PFAA in adult general populations (Fromme et al., 2009; Trudel et al., 2008; Vestergren and Cousins, 2009; Tittlemier et al., 2007), food intake by women in these life stages is probably the most important exposure route to consider when estimatin…”
Background
Exposure of Perfluorinated Chemicals through Lactation: Levels of Matched Human Milk and Serum and a Temporal Trend, 1996–2004, in Sweden
Kärrman, A., Ericson, I., van Bavel, B., Darnerud, P. O., Aune, M., Glynn, A. W., Lignell, S., & Lindström, G. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9491 · Cited by 475
Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy
Inoue, K., Okada, F., Ito, R., Kato, S., Sasaki, S., 中島そのみ, Uno, A., Saijo, Y., Sata, F., Yoshimura, Y., et al. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6864 · Cited by 468
Dietary Exposure of Canadians to Perfluorinated Carboxylates and Perfluorooctane Sulfonate via Consumption of Meat, Fish, Fast Foods, and Food Items Prepared in Their Packaging
Tittlemier, S. A., Pepper, K., Seymour, C., Moisey, J., Bronson, R., Cao, X., & Dabeka, R. W. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0634045 · Cited by 448
Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. I: Maternal and Prenatal Evaluations
Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., & Lau, C. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg121 · Cited by 445
Tracking the Pathways of Human Exposure to Perfluorocarboxylates
Vestergren, R., & Cousins, I. T. (2009) · Environmental Science & Technology · doi:10.1021/es900228k · Cited by 436
Binding of Perfluorooctanoic Acid to Rat and Human Plasma Proteins
Han, X., Snow, T. A., Kemper, R. A., & Jepson, G. W. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034005w · Cited by 422
Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta
Ho, S., Sekine, T., Kusuhara, H., Yu, E., Kim, J. Y., Kim, D. K., Sugiyama, Y., Kanai, Y., & Endou, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4507 · Cited by 407
Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia
Bartell, S. M., Calafat, A. M., Lyu, C. W., Kato, K., Ryan, P. B., & Steenland, K. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901252 · Cited by 397
Characterisation of human exposure pathways to perfluorinated compounds — Comparing exposure estimates with biomarkers of exposure
Haug, L. S., Huber, S., Becher, G., & Thomsen, C. (2011) · Environment International · doi:10.1016/j.envint.2011.01.011 · Cited by 391
Biomonitoring of Perfluorinated Compounds in Children and Adults Exposed to Perfluorooctanoate-Contaminated Drinking Water
Hölzer, J., Midasch, O., Rauchfuss, K., Kraft, M., Reupert, R., Angerer, J., Kleeschulte, P., Marschall, N., & Wilhelm, M. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11064 · Cited by 363
Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure Sources
Emmett, E. A., Shofer, F. S., Zhang, H., Freeman, D. W., Desai, C. S., & Shaw, L. M. J. (2006) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000232486.07658.74 · Cited by 357
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals
Ehresman, D. J., Froehlich, J. W., Olsen, G. W., Chang, S., & Butenhoff, J. L. (2006) · Environmental Research · doi:10.1016/j.envres.2006.06.008 · Cited by 353
Pre- and Postnatal Exposure to Perfluorinated Compounds (PFCs)
Fromme, H., Mosch, C., Morovitz, M., Alba‐Alejandre, I., Boehmer, S., Kiranoglu, M., Faber, F. L., Hannibal, I., Genzel‐Boroviczény, O., Koletzko, B. V., et al. (2010) · Environmental Science & Technology · doi:10.1021/es101184f · Cited by 339
Perfluoroalkyl Acids and Related Chemistries—Toxicokinetics and Modes of Action
Andersen, M. E., Butenhoff, J. L., Chang, S., Farrar, D. G., Kennedy, G. L., Lau, C. S., Olsen, G. W., Seed, J. G., & Wallace, K. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm270 · Cited by 322
Self-citation
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague–Dawley rats: Dose–response, and biochemical and pharamacokinetic parameters
Luebker, D. J., York, R. G., Hansen, K. J., Moore, J. A., & Butenhoff, J. L. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.019 · Cited by 314
Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples
Monroy, R., Morrison, K. M., Teo, K. K., Atkinson, S. A., Kubwabo, C., Stewart, B., & Foster, W. G. (2008) · Environmental Research · doi:10.1016/j.envres.2008.06.001 · Cited by 313
Correlations between Prenatal Exposure to Perfluorinated Chemicals and Reduced Fetal Growth
Washino, N., Saijo, Y., Sasaki, S., Kato, S., Ban, S., Konishi, K., Ito, R., Nakata, A., Iwasaki, Y., Saito, K., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11681 · Cited by 300
SERIAL CHANGES IN RENAL HAEMODYNAMICS DURING NORMAL HUMAN PREGNANCY
Dunlop, W. (1981) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb00929.x · Cited by 299
Perfluoroalkyl chemicals and human fetal development: An epidemiologic review with clinical and toxicological perspectives
Olsen, G. W., Butenhoff, J. L., & Zobel, L. R. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.001 · Cited by 293
Sex hormone-regulated renal transport of perfluorooctanoic acid
Kudo, N., Katakura, M., Sato, Y., & Kawashima, Y. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00006-6 · Cited by 293
Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion
Harada, K. H., Inoue, K., Morikawa, A., Yoshinaga, T., Saito, N., & Koizumi, A. (2005) · Environmental Research · doi:10.1016/j.envres.2004.12.003 · Cited by 293
Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats
Heuvel, J. P. V., Kuslikis, B. I., Rafelghem, M. J. V., & Peterson, R. E. (1991) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570060202 · Cited by 289
Physiology and Endocrine Changes Underlying Human Lactogenesis II
Neville, M. C., & Morton, J. (2001) · Journal of Nutrition · doi:10.1093/jn/131.11.3005s · Cited by 285
Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats
Luebker, D. J., Case, M. T., York, R. G., Moore, J. A., Hansen, K. J., & Butenhoff, J. L. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.018 · Cited by 274
Perfluorooctanoic Acid Induced Developmental Toxicity in the Mouse is Dependent on Expression of Peroxisome Proliferator Activated Receptor-alpha
Abbott, B. D., Wolf, C. J., Schmid, J., Das, K. P., ZEHR, R. D. J., Helfant, L., Nakayama, S. F., Lindstrom, A. B., Strynar, M. J., & Lau, C. S. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm110 · Cited by 271
Levels of Perfluorinated Compounds in Food and Dietary Intake of PFOS and PFOA in The Netherlands
Noorlander, C. W., van Leeuwen, S. P. J., Biesebeek, J. D. T., Mengelers, M. J. B., & Zeilmaker, M. J. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf104943p · Cited by 265
Pharmacokinetics in the newborn.
Alcorn, J., & McNamara, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00030-9 · Cited by 252
Renal elimination of perfluorocarboxylates (PFCAs)
Han, X., Nabb, D. L., Russell, M. H., Kennedy, G. L., & Rickard, R. W. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200363w · Cited by 250
Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones
Kim, S., Choi, K., Ji, K., Seo, J., Kho, Y., Park, J., Kim, S., Park, S., Hwang, I., Jeon, J.-K., et al. (2011) · Environmental Science & Technology · doi:10.1021/es202408a · Cited by 250
Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study
Midasch, O., Drexler, H., Hart, N., Beckmann, M. W., & Angerer, J. (2007) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-006-0165-9 · Cited by 245
Decline in Perfluorooctanesulfonate and Other Polyfluoroalkyl Chemicals in American Red Cross Adult Blood Donors, 2000−2006
Olsen, G. W., Mair, D. C., Church, T. R., Ellefson, M. E., Reagen, W. K., Boyd, T. M., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., Rios, J. A., et al. (2008) · Environmental Science & Technology · doi:10.1021/es800071x · Cited by 244
Serial Studies of Renal Function During Pregnancy and the Puerperium in Normal Women12
Sims, E. A. H., & Krantz, K. E. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103769 · Cited by 239
Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.
White, S., Calafat, A., Kuklenyik, Z., Villanueva, L. R., Zehr, R. D., Helfant, L., Strynar, M., Lindstrom, A., Thibodeaux, J. R., Wood, C., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl177 · Cited by 229
Time Course of Maternal Plasma Volume and Hormonal Changes in Women With Preeclampsia or Fetal Growth Restriction
Salas, S. P., Marshall, G., Gutiérrez, B. L., & Rosso, P. (2005) · Hypertension · doi:10.1161/01.hyp.0000200042.64517.19 · Cited by 218
Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys—Probing the determinants of long plasma half-lives
Andersen, M. E., M.A., H. J. C. I., Tan, Y., Butenhoff, J. L., & Olsen, G. W. (2006) · Toxicology · doi:10.1016/j.tox.2006.08.004 · Cited by 210
Self-citation
Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates
Yang, C.-H., Glover, K. P., & Han, X. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq219 · Cited by 197
Estimating the contribution of precursor compounds in consumer exposure to PFOS and PFOA
Vestergren, R., Cousins, I. T., Trudel, D., Wormuth, M., & Scheringer, M. (2008) · Chemosphere · doi:10.1016/j.chemosphere.2008.08.011 · Cited by 194
Isomer Profiles of Perfluorochemicals in Matched Maternal, Cord, and House Dust Samples: Manufacturing Sources and Transplacental Transfer
Beesoon, S., Webster, G. M., Shoeib, M., Harner, T., Benskin, J. P., & Martin, J. W. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003265 · Cited by 190
Disposition of perfluorinated acid isomers in sprague-dawley rats; Part 1: Single dose
Benskin, J. P., Silva, A. O. D., Martin, L. J., Arsenault, G. J., McCrindle, R. I., Riddell, N., Mabury, S. A., & Martin, J. W. (2008) · Environmental Toxicology and Chemistry · doi:10.1897/08-239.1 · Cited by 178
Roles of Rat Renal Organic Anion Transporters in Transporting Perfluorinated Carboxylates with Different Chain Lengths
Weaver, Y. M., Ehresman, D. J., Butenhoff, J. L., & Hagenbuch, B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp275 · Cited by 178
Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: Results of a pilot study
Völkel, W., Genzel‐Boroviczény, O., Demmelmair, H., Gebauer, C. M., Koletzko, B. V., Twardella, D., Raab, U., & Fromme, H. (2007) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2007.07.024 · Cited by 176
Comparison on gestation and lactation exposure of perfluorinated compounds for newborns
Liu, J., Li, J., Liu, Y., Chan, H. M., Zhao, Y., Cai, Z., & Wu, Y. (2011) · Environment International · doi:10.1016/j.envint.2011.05.001 · Cited by 174
Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium 614C9perfluorooctanoate or potassium 614C9perfluorooctanesulfonate
JOHNSON, J. (1984) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(84)90235-5 · Cited by 161
Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures
Kim, S., Lee, K. T., Kang, C. S., Tao, L., Kannan, K., Kim, K., Kim, C.-K., Lee, J. S., Park, P. S., Yoo, Y. W., et al. (2010) · Environmental Pollution · doi:10.1016/j.envpol.2010.09.008 · Cited by 161
Changes in Concentrations of Perfluorinated Compounds, Polybrominated Diphenyl Ethers, and Polychlorinated Biphenyls in Norwegian Breast-Milk during Twelve Months of Lactation
Thomsen, C., Haug, L. S., Stigum, H., Frøshaug, M., Broadwell, S. L., & Becher, G. (2010) · Environmental Science & Technology · doi:10.1021/es1021922 · Cited by 157
Adequacy of energy intake among breast-fed infants in the DARLING study: Relationships to growth velocity, morbidity, and activity levels
Dewey, K. G., Heinig, M. J., Nommsen, L. A., & Lönnerdal, B. L. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82401-1 · Cited by 152
Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model
Loccisano, A. E., Campbell, J. L., Andersen, M. E., & M.A., H. J. C. I. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.12.004 · Cited by 145
Self-citation
Iron status and iron balance during pregnancy. A critical reappraisal of iron supplementation
Milman, N. T., Bergholt, T., Byg, K., Eriksen, L., & Graudal, N. A. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.780902.x · Cited by 145
Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements
Raymer, J. H., Michael, L. C., Studabaker, W. B., Olsen, G. W., Sloan, C. S., Wilcosky, T. C., & Walmer, D. K. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.05.024 · Cited by 144
Infant exposure of perfluorinated compounds: Levels in breast milk and commercial baby food
Llorca, M., Farré, M., Picó, Y., Teijón, M. L., Álvarez, J. G., & Barceló, ‪. (2010) · Environment International · doi:10.1016/j.envint.2010.04.016 · Cited by 140
Evaluation of the Uncertainty in an Oral Reference Dose for Methylmercury Due to Interindividual Variability in Pharmacokinetics
M.A., H. J. C. I., Gearhart, J. M., Gentry, P. R., Covington, T. R., VanLandingham, C. B., Crump, K. S., & Shipp, A. M. (1999) · Risk Analysis · doi:10.1023/a:1007017116171 · Cited by 138
Drug disposition and pharmacokinetics in the maternal-placental-fetal unit
Krauer, B., Krauer, F., & Hytten, F. E. (1980) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(80)90085-6 · Cited by 135
Plasma Protein Binding of Drugs in Pregnancy
Perucca, E., & Crema, A. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207040-00004 · Cited by 134
Renal physiology in pregnancy
Dunlop, W. (1979) · Postgraduate Medical Journal · doi:10.1136/pgmj.55.643.329 · Cited by 134
Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study
Hanssen, L., Röllin, H. B., Odland, J. Ø., Moe, M. K., & Sandanger, T. M. (2010) · Journal of Environmental Monitoring · doi:10.1039/b924420d · Cited by 134
Plasma Protein Binding of Drugs in Pregnancy and in Neonates
Notarianni, L. J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018010-00002 · Cited by 127
Roles of Organic Anion Transporters in the Renal Excretion of Perfluorooctanoic Acid
Nakagawa, H., Hirata, T., Terada, T., Jutabha, P., Miura, D., Harada, K. H., Inoue, K., Anzai, N., Endou, H., Inui, K., et al. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00155.x · Cited by 119
Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat
Grasty, R. C., Bjork, J. A., Wallace, K. B., Lau, C. S., & Rogers, J. M. (2005) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20059 · Cited by 117
Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction
Duvekot, J. J., Cheriex, E. C., Pieters, F. A. A., Menheere, P. P. C. A., Schouten, H. J. A., & Peeters, L. L. H. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(94)00417-c · Cited by 116
Modeling Single and Repeated Dose Pharmacokinetics of PFOA in Mice
Lou, I., Wambaugh, J. F., Lau, C. S., Hanson, R. G., Lindstrom, A. B., Strynar, M. J., ZEHR, R. D. J., Setzer, R. W., & Barton, H. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn234 · Cited by 115
Rat and Rabbit Oral Developmental Toxicology Studies With Two Perfluorinated Compounds
Case, R. G. Y. M. T. (2001) · International Journal of Toxicology · doi:10.1080/10915810151115236 · Cited by 114
Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women
Ehrenstein, O. S. V., Fenton, S. E., Kato, K., Kuklenyik, Z., Calafat, A. M., & Hines, E. P. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.03.001 · Cited by 110
Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats
Yang, C., Glover, K., & Han, X. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.07.011 · Cited by 104
Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats.
Hinderliter, P., Mylchreest, E., Gannon, S. A., Butenhoff, J., & Kennedy, G. (2005) · Toxicology · doi:10.1016/j.tox.2005.03.010 · Cited by 101
Regulation of Amniotic Fluid Volume
Beall, M. H., van den Wijngaard, J. P. H. M., van Gemert, M. J. C., & Ross, M. G. (2007) · Placenta · doi:10.1016/j.placenta.2006.12.004 · Cited by 94
Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation
Gentry, P. R., Covington, T. R., & M.A., H. J. C. I. (2003) · Regulatory Toxicology and Pharmacology · doi:10.1016/s0273-2300(03)00047-3 · Cited by 91
Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model
Loccisano, A. E., Campbell, J. L., Butenhoff, J. L., Andersen, M. E., & M.A., H. J. C. I. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.04.006 · Cited by 83
Self-citation
Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse
Tatum-Gibbs, K. R., Wambaugh, J. F., Das, K. P., ZEHR, R. D. J., Strynar, M. J., Lindstrom, A. B., Delinsky, A. D., & Lau, C. S. (2011) · Toxicology · doi:10.1016/j.tox.2011.01.003 · Cited by 82
Tissue Distribution and Hepatic Subcellular Distribution of Perfluorooctanoic Acid at Low Dose Are Different from Those at High Dose in Rats
Kudo, N., Sakai, A., Mitsumoto, A., Hibino, Y., Tsuda, T., & Kawashima, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1535 · Cited by 81
Analysis of PFOA in dosed CD-1 mice. Part 2: Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups
Fenton, S., Reiner, J. L., Nakayama, S., Delinsky, A. D., Stanko, J., Hines, E., White, S., Lindstrom, A., Strynar, M., & Petropoulou, S.-S. E. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.012 · Cited by 80
Intake of tapwater and total water by pregnant and lactating women.
Ershow, A. G., Brown, L. M., & Cantor, K. P. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.3.328 · Cited by 79
Metabolic Handling of Perfluorooctanoic Acid in Rats
Ophaug, R. H., & Singer, L. (1980) · Experimental Biology and Medicine · doi:10.3181/00379727-163-40715 · Cited by 77
Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid
Nakagawa, H., Terada, T., Harada, K. H., Hitomi, T., Inoue, K., Inui, K., & Koizumi, A. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00409.x · Cited by 76
Time dependencies in perfluorooctylacids disposition in rat and monkeys: A kinetic analysis
Tan, Y., M.A., H. J. C. I., & Andersen, M. E. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.12.007 · Cited by 75
Self-citation
Gender Difference in the Urinary Excretion of Organic Anions in Rats
Kato, Y., Kuge, K., Kusuhara, H., Meier, P. J., & Sugiyama, Y. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033878 · Cited by 71
Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model
Loccisano, A. E., Campbell, J. L., Butenhoff, J. L., Andersen, M. E., & M.A., H. J. C. I. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.07.003 · Cited by 70
Self-citation
Application of a Physiologically Based Pharmacokinetic Model for Isopropanol in the Derivation of a Reference Dose and Reference Concentration
Gentry, P. R., Covington, T. R., Andersen, M. E., & M.A., H. J. C. I. (2002) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2002.1540 · Cited by 66
Self-citation
The blood volume of infants
Sisson, T. R. C., Lund, C. J., Whalen, L. E., & Telek, A. (1959) · The Journal of Pediatrics · doi:10.1016/s0022-3476(59)80084-6 · Cited by 65
Rat Organic Anion Transporter 3 and Organic Anion Transporting Polypeptide 1 Mediate Perfluorooctanoic Acid Transport
Katakura, M., Kudo, N., Tsuda, T., Hibino, Y., Mitsumoto, A., & Kawashima, Y. (2007) · Eisei kagaku · doi:10.1248/jhs.53.77 · Cited by 64
The blood volume of infants
Sisson, T. R. C., & Whalen, L. E. (1960) · The Journal of Pediatrics · doi:10.1016/s0022-3476(60)80287-9 · Cited by 51
Lactation, weaning, and calcium supplementation: effects on body composition in postpartum women
Wosje, K. S., & Kalkwarf, H. J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.423 · Cited by 49
Lack of evidence for perfluorodecanoyl‐ or perfluorooctanoyl‐coenzyme a formation in male and female rats
Kuslikis, B. I., Heuvel, J. P. V., & Peterson, R. E. (1992) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570070106 · Cited by 49
Pharmacokinetic modeling of perfluorooctanoic acid during gestation and lactation in the mouse
Rodriguez, C. E., Setzer, R. W., & Barton, H. A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.009 · Cited by 23
Modeling single and repeated dose pharmacokinetics of PFOA in mice
Wambaugh, J. F., Lou, I., Lau, C. S., Hanson, R. G., Lindstrom, A. B., Strynar, M. J., ZEHR, R. D. J., Setzer, R. W., & Barton, H. A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.11.083 · Cited by 23
Presence of anionic perfluorinated organic compounds in serum collected from Northern Canadian populations
Tittlemier, S. A., Ryan, J. J., & Oostdam, J. V. (2004) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 20
Biological-Mathematical Modeling of Chronic Toxicity.
Thomas, V. (1981) · doi:10.21236/ada105086 · Cited by 16
Perfluoroalkyl acids: Recent activities and research progress
Lau, C. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.011 · Cited by 14

Research works printed but not linked: 12

Apelberg B.J., 2007, Health. Perspect.115:1670.
Centers for Disease Control and Prevention, 2004, Morbid. Mortal Weekly Rep, 1971
Clewell H.J., 1999, Risk Anal., 19, 547
Ehresman D.J., 2007, Res., 103, 176
Gentry P.R., 2002, Toxicol. Pharmacol., 36, 51
Gentry P.R., 2003, Toxicol. Pharmacol., 38, 1
Kerstner-Wood C., 2003, Birmingham, AL: Southern Research Corporation.
Loccisano A.E., 2012, Toxicol., 33, 468
Milman N., 1999, Acta Obstet. Gynecol. Scand., 78, 749, 10.1080/j.1600-0412.1999.780902.x · DOI
Olsen G.W., 2009, Toxicol., 27, 212
Raymer J.H., 2012, Toxicol., 33, 419
Sisson T.R.C., 1959, J. Pediat., 55:163

Sorted by citations

Risk to human health related to the presence of perfluoroalkyl substances in food
Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989
Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B. J., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5194 · Cited by 549
Early Life Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Latent Health Outcomes: A Review Including the Placenta as a Target Tissue and Possible Driver of Peri- and Postnatal Effects
Blake, B. E., & Fenton, S. E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152565 · Cited by 499
Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: A systematic review
Bach, C. C., Bech, B. H., Brix, N., Nohr, E. A., Bonde, J. P., & Henriksen, T. B. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.952400 · Cited by 311
Per- and polyfluorinated substances (PFASs): Environmental challenges
Krafft, M. P., & Riess, J. G. (2015) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2015.07.004 · Cited by 294

See all 144

Authors: Loccisano, A. E., Longnecker, M. P., Campbell, J. L., Andersen, M. E., & Clewell, H. J.
Affiliations: The Hamner Institutes for Health Sciences (US)
National Institutes of Health (US)
Center for Human Health Assessment, The Hamner Institutes for Health Sciences , Research Triangle Park, North Carolina, USA
Corresponding author: Loccisano, Anne E.
ORCID: Loccisano, Anne E.
Longnecker, Matthew P.
Campbell, Jerry L.
Andersen, Melvin E.
Venue: Journal of Toxicology and Environmental Health, Part A
Publisher: Informa UK Limited
Published: 2012-11-14
Volume: 76
Issue: 1
Pages: 25-57
ISSN: 0098-4108 (ISSN-L)
1528-7394
1087-2620
DOI: 10.1080/15287394.2012.722523
PMC: PMC3502013
OpenAlex: W2049985148
Cited by: 141
References: 109
Citations by year: 2026: 6 · 2025: 8 · 2024: 8 · 2023: 17 · 2022: 4 · 2021: 12 · 2020: 13 · 2019: 13 · 2018: 12 · 2017: 11 · 2016: 5 · 2015: 14 · 2014: 11 · 2013: 5
FWCI: 7.68
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Toxicology and Environmental Health (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Environmental Health Sciences (ZIAES044008)
Topics: Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords: perfluorooctanoic acid, PFOS, perfluoroalkyl acids, physiologically based pharmacokinetic modeling, human pregnancy, lactation, fetal pharmacokinetics, maternal exposure, milk concentration, clearance, developmental toxicity
MeSH terms: Adult, Animals, Haplorhini, Caprylates, Computer Simulation, Female, Fluorocarbons, Humans, Infant, Newborn, Kidney, Lactation, Maternal-Fetal Exchange, Models, Biological, Pregnancy, Protein Binding, Risk Factors, Alkanesulfonic Acids, Maternal Exposure, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks